Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

NCT00039676 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00039676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00039676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Active, not recruiting
Start date
July 8, 2002
Completion date
Not reported
Enrollment
1,836 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, hodgkin disease, mixed lymphoproliferative disease, nonhodgkin lymphoma, waldenstrom macroglobulinemia